Related Experiment Video
Updated: Aug 4, 2026
09:40
Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2
Margit Rosner1, Markus Hengstschläger
1Medical University of Vienna, Obstetrics and Gynecology, Prenatal Diagnosis and Therapy, Währinger Gürtel 18-20, 1090 Vienna, Austria.
The Journal of Biological Chemistry
|September 10, 2004
Summary
Tuberin, a protein from tuberous sclerosis complex 2 (TSC2), directly binds to p27, preventing its degradation and halting cell cycle progression. This discovery explains how TSC genes regulate cell growth and tumor suppression.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in TSC1 (hamartin) and TSC2 (tuberin) tumor suppressor genes.
- TSC genes negatively regulate cell cycle progression, cdk2 activity, and p27 degradation, but the molecular mechanism is unclear.
- p27 is a cyclin-dependent kinase inhibitor whose stability is regulated by ubiquitin-dependent degradation via the SCFSkp2 E3 ubiquitin ligase complex.
Purpose of the Study:
- To elucidate the molecular mechanism by which TSC1 and TSC2 regulate cell cycle progression.
- To investigate the direct interaction between tuberin (TSC2) or hamartin (TSC1) and the p27 protein.
- To understand how this interaction affects p27 stability and cell cycle control.
Main Methods:
- Co-immunoprecipitation assays to detect protein-protein interactions.
- Western blotting to assess protein levels and degradation.
- Analysis of p27 binding to cdk2 and its sequestration from Skp2.
Main Results:
- Tuberin directly binds to p27; hamartin requires tuberin to bind p27.
- Tuberin binding to p27 sequesters p27 from the SCFSkp2 ligase complex, preventing p27 degradation.
- This interaction leads to increased p27-cdk2 complex formation, inhibiting cell cycle progression.
Conclusions:
- This study provides the first direct evidence of a tumor suppressor protein interacting with p27.
- Tuberin's binding to p27 offers a molecular explanation for the cell cycle regulatory effects of TSC genes.
- A novel mechanism of SCFSkp2-mediated p27 regulation is demonstrated, involving sequestration by tuberin.
Related Concept Videos
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
01:45Destabilization of Microtubules
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...